Author

Michael Vieth

INTRODUCTION AND PRELIMINARY CLINICAL EVALUATION OF NOVEL ENDOSCOPE WITH PINPOINT LASER TECHNOLOGY FOR ADEQUATE SIZE ESTIMATION OF COLON LESIONS
INTRODUCTION AND PRELIMINARY CLINICAL EVALUATION OF NOVEL ENDOSCOPE WITH PINPOINT LASER TECHNOLOGY FOR ADEQUATE SIZE ESTIMATION OF COLON LESIONS

Michael Vieth  et al.

HISTOPATHOLOGY BUT NOT MENTAL HEALTH ASSESSMENT DISTINGUISHES INDIVIDUALS WITH AND WITHOUT EROSIVE REFLUX DISEASE AND CONTROLS WITHOUT REFLUX DISEASE – A CROSS-SECTIONAL POPULATION-BASED STUDY
HISTOPATHOLOGY BUT NOT MENTAL HEALTH ASSESSMENT DISTINGUISHES INDIVIDUALS WITH AND WITHOUT EROSIVE REFLUX DISEASE AND CONTROLS WITHOUT REFLUX DISEASE – A CROSS-SECTIONAL POPULATION-BASED STUDY

Michael Vieth  et al.

BUDESONIDE ORODISPERSIBLE TABLETS ARE ABLE TO MAINTAIN CLINICAL, HISTOLOGICAL AND ENDOSCOPIC REMISSION IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE FIRST 48-WEEKS OPEN-LABEL EXTENSION PHASE OF THE 1-YEAR DOUBLE-BLIND EOS-2 TRIAL
BUDESONIDE ORODISPERSIBLE TABLETS ARE ABLE TO MAINTAIN CLINICAL, HISTOLOGICAL AND ENDOSCOPIC REMISSION IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE FIRST 48-WEEKS OPEN-LABEL EXTENSION PHASE OF THE 1-YEAR DOUBLE-BLIND EOS-2 TRIAL

Michael Vieth  et al.

A RARE CASE OF COLLAGENOUS GASTRITIS IN A 16 YEAR OLD MALE PATIENT
A RARE CASE OF COLLAGENOUS GASTRITIS IN A 16 YEAR OLD MALE PATIENT

Michael Vieth  et al.

BUDESONIDE ORODISPERSIBLE TABLETS ARE ABLE TO MAINTAIN CLINICAL, HISTOLOGICAL AND ENDOSCOPIC REMISSION IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE 96-WEEKS OPEN-LABEL EXTENSION PHASE FOLLOWINGTHE 1-YEAR DOUBLE-BLIND EOS-2 TRIAL
BUDESONIDE ORODISPERSIBLE TABLETS ARE ABLE TO MAINTAIN CLINICAL, HISTOLOGICAL AND ENDOSCOPIC REMISSION IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE 96-WEEKS OPEN-LABEL EXTENSION PHASE FOLLOWINGTHE 1-YEAR DOUBLE-BLIND EOS-2 TRIAL

Michael Vieth  et al.

Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline

Michael Vieth  et al.

GASTROESOPHAGEAL REFLUX DISEASE AND DE NOVO INCIDENCE OF BARRETT’S ESOPHAGUS >=5 YEARS AFTER LAPAROSCOPIC SLEEVE GASTRECTOMY OR ROUX-Y-GASTRIC BYPASS
GASTROESOPHAGEAL REFLUX DISEASE AND DE NOVO INCIDENCE OF BARRETT’S ESOPHAGUS >=5 YEARS AFTER LAPAROSCOPIC SLEEVE GASTRECTOMY OR ROUX-Y-GASTRIC BYPASS

Michael Vieth  et al.

S2k-Guideline Helicobacter pylori and gastroduodenal ulcer disease
S2k-Guideline Helicobacter pylori and gastroduodenal ulcer disease

Michael Vieth  et al.

AN ARTIFICIAL INTELLIGENCE SYSTEM TO DETECT HISTOLOGICAL REMISSION AND PREDICT CLINICAL OUTCOMES IN ULCERATIVE COLITIS PATIENTS
AN ARTIFICIAL INTELLIGENCE SYSTEM TO DETECT HISTOLOGICAL REMISSION AND PREDICT CLINICAL OUTCOMES IN ULCERATIVE COLITIS PATIENTS

Michael Vieth  et al.

A VIRTUAL CHROMOENDOSCOPY ARTIFICIAL INTELLIGENCE SYSTEM TO DETECT ENDOSCOPIC AND HISTOLOGIC ACTIVITY/REMISSION AND PREDICT CLINICAL OUTCOMES IN ULCERATIVE COLITIS
A VIRTUAL CHROMOENDOSCOPY ARTIFICIAL INTELLIGENCE SYSTEM TO DETECT ENDOSCOPIC AND HISTOLOGIC ACTIVITY/REMISSION AND PREDICT CLINICAL OUTCOMES IN ULCERATIVE COLITIS

Michael Vieth  et al.

Item 1 - 10 / 10
1